Approval · Notice of Compliance 21790 · 2019
BARACLUDE: Notice of Compliance 21790
Issued January 24, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21790
- Date
- January 24, 2019
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- To update labels to meet plain language requirements
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BARACLUDE | Not yet assigned | — |
Medicinal ingredients
- ENTECAVIR 0.5 MG per TAB